litlas
ログインアカウント作成

Nicolas Girard

2006–2025 年に発表

242
論文数
23,651
被引用数
82
h 指数
212
i10 指数

被引用数

Nicolas Girard の年別被引用数1971 年: 被引用 2 件2000 年: 被引用 1 件2002 年: 被引用 4 件2003 年: 被引用 2 件2007 年: 被引用 1 件2008 年: 被引用 4 件2009 年: 被引用 4 件2010 年: 被引用 23 件2011 年: 被引用 44 件2012 年: 被引用 67 件2013 年: 被引用 69 件2014 年: 被引用 73 件2015 年: 被引用 96 件2016 年: 被引用 116 件2017 年: 被引用 86 件2018 年: 被引用 116 件2019 年: 被引用 492 件2020 年: 被引用 741 件2021 年: 被引用 831 件2022 年: 被引用 768 件2023 年: 被引用 966 件2024 年: 被引用 1,762 件2025 年: 被引用 1,106 件2026 年: 被引用 42 件1972〜1999 年は被引用が無いため表示していません2001 年は被引用が無いため表示していません2004〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,148 件、この内訳の 19.9%中国: 引用元論文 1,711 件、この内訳の 15.9%フランス: 引用元論文 663 件、この内訳の 6.2%イタリア: 引用元論文 653 件、この内訳の 6.1%イギリス: 引用元論文 551 件、この内訳の 5.1%ドイツ: 引用元論文 488 件、この内訳の 4.5%日本: 引用元論文 479 件、この内訳の 4.4%スペイン: 引用元論文 387 件、この内訳の 3.6%カナダ: 引用元論文 369 件、この内訳の 3.4%オランダ: 引用元論文 333 件、この内訳の 3.1%スイス: 引用元論文 272 件、この内訳の 2.5%韓国: 引用元論文 270 件、この内訳の 2.5%
0%19.9%その他 22.8%

機関

分野

  • Medicine71.8%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Computer Science4.7%
  • Immunology and Microbiology2.5%
  • Engineering2.3%
  • Neuroscience1.5%
  • その他2.4%

トピック

  • Lung Cancer Treatments and Mutations10%
  • Cancer Immunotherapy and Biomarkers8.5%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Lung Cancer Research Studies5.5%
  • Cancer Genomics and Diagnostics3.5%
  • Radiomics and Machine Learning in Medical Imaging2.5%
  • その他63.9%

共著者

全論文

検索で開く
  1. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

    著者: Patrick M. Forde, Jonathan Spicer, Shun Lu, Mariano Provencio, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen R. Broderick, Julie R. Brahmer, Scott J. Swanson, Keith Kerr, Changli Wang, Tudor-Eliade Ciuleanu, Gene B. Saylors, Fumihiro Tanaka, Hiroyuki Ito, Ke-Neng Chen, Moishe Liberman, Everett E. Vokes, Janis M. Taube, Cecile Dorange, Junliang Cai, Joseph Fiore, Anthony Jarkowski, David Balli, Mark Sausen, Dimple Pandya, Christophe Y. Calvet, Nicolas Girard - New England Journal of Medicine 2022 被引用: 2,558

  2. Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

    著者: Antonio Passaro, Jing Wang, Yan Wang, S.-H. Lee, Barbara Melosky, Jin‐Yuan Shih, Jing Wang, K. Azuma, Óscar Juan, Manuel Cobo, Enriqueta Felip, Nicolas Girard, Alexis B. Cortot, Raffaele Califano, Federico Cappuzzo, Scott Owen, Sanjay Popat, Ju Le Tan, Jorge Salinas, Pascale Tomasini, Ryan D. Gentzler, William N. William, Karen L. Reckamp, Toshiaki Takahashi, Sandip Ganguly, Dariusz M. Kowalski, Alessandra Bearz, Melanie Mackean, P. Barala, Ariel B. Bourla, Angela Girvin, James Greger, Dawn Millington, Monica Withelder, John Xie, Tao Sun, Shalin Shah, B. Diorio, Roland E. Knoblauch, Joshua Bauml, Rosario García Campelo, Byoung Chul Cho - Annals of Oncology 2023 被引用: 396

  3. Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors

    著者: John A. Grout, Philémon Sirven, Andrew M. Leader, Shrisha Maskey, Eglantine Hector, Isabelle Puisieux, Fiona Steffan, Evan Cheng, Navpreet Tung, Mathieu Maurin, Romain Vaineau, Léa Karpf, Martin Plaud, Anne-Laure Bègue, Koushik Ganesh, Jérémy Mesple, María Casanova-Acebes, Alexandra Tabachnikova, Shilpa Keerthivasan, Alona Lansky, Jessica Le Bérichel, Laura Walker, Adeeb Rahman, Sacha Gnjatic, Nicolas Girard, Marine Lefèvre, Diane Damotte, Julien Adam, J.P. Martin, Andrea Wolf, Raja M. Flores, Mary Beth Beasley, Rachana Pradhan, Sören Müller, Thomas U. Marron, Shannon J. Turley, Miriam Mérad, Ephraim Kenigsberg, Hélène Salmon - Cancer Discovery 2022 被引用: 315

  4. Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

    著者: Keunchil Park, Eric B. Haura, Natasha B. Leighl, Paul Mitchell, Catherine A. Shu, Nicolas Girard, Santiago Viteri, Ji‐Youn Han, Sang‐We Kim, Chee Khoon Lee, Joshua K. Sabari, Alexander I. Spira, Tsung‐Ying Yang, Dong‐Wan Kim, Ki Hyeong Lee, Rachel E. Sanborn, José Trigo, Kōichi Goto, Jong‐Seok Lee, James Chih‐Hsin Yang, Ramaswamy Govindan, Joshua Bauml, Pilar Garrido, Matthew Krebs, Karen L. Reckamp, John Xie, Joshua C. Curtin, Nahor Haddish‐Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E. Knoblauch, Byoung Chul Cho - Journal of Clinical Oncology 2021 被引用: 632

  5. Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions

    著者: Caicun Zhou, Kejing Tang, Byoung Chul Cho, Baogang Liu, Luis Paz‐Ares, Susanna Y. Cheng, Satoru Kitazono, Muthukkumaran Thiagarajan, Jonathan W. Goldman, Joshua K. Sabari, Rachel E. Sanborn, Aaron S. Mansfield, Jen‐Yu Hung, Michael Boyer, Sanjay Popat, Josiane Mourão Dias, Enriqueta Felip, Margarita Majem, Mahmut Gümüş, Sang‐We Kim, Akira Ono, John Xie, Archan Bhattacharya, Trishala Agrawal, S. Martin Shreeve, Roland E. Knoblauch, Keunchil Park, Nicolas Girard - New England Journal of Medicine 2023 被引用: 347

  6. Deep learning-based classification of mesothelioma improves prediction of patient outcome

    著者: Pierre Courtiol, Charles Maussion, Matahi Moarii, Elodie Pronier, Samuel Pilcer, Meriem Sefta, Pierre Manceron, Sylvain Toldo, Mikhail Zaslavskiy, Nolwenn Le Stang, Nicolas Girard, Olivier Elemento, Andrew G. Nicholson, Jean‐Yves Blay, Françoise Galateau-Sallé, Gilles Wainrib, Thomas Clozel - Nature Medicine 2019 被引用: 552

  7. Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC

    著者: Byoung Chul Cho, Shun Lu, Enriqueta Felip, Alexander I. Spira, Nicolas Girard, Jong-Seok Lee, Se-Hoon Lee, Yurii Ostapenko, Pongwut Danchaivijitr, Baogang Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Benjamin Besse, Ki-Hyeong Lee, Hailin Xiong, Soon-Hin How, Ying Cheng, Gee‐Chen Chang, Hiroshige Yoshioka, James Chih‐Hsin Yang, Michael J. Thomas, Danny Nguyen, Sai‐Hong Ignatius Ou, Sanjay Mukhedkar, Kumar Prabhash, M. D’Arcangelo, Jorge Alatorre-Alexander, Juan Carlos Vázquez Limón, Sara Alves, Daniil Stroyakovskiy, Marina Peregudova, Mehmet Alı Nahıt Şendur, Ozan Yazıcı, Raffaele Califano, Vanesa Gutiérrez Calderón, Filippo de Marinis, Antonio Passaro, Sang‐We Kim, Shirish M. Gadgeel, John Xie, Tao Sun, Melissa Martínez, Mariah Ennis, E. Fennema, Mahesh Daksh, Dawn Millington, Isabelle Leconte, Ryota Iwasawa, Patricia Lorenzini, Mahadi Baig, Sujay Shah, Joshua Bauml, S. Martin Shreeve, Seema Sethi, R.E. Knoblauch, Hidetoshi Hayashi - New England Journal of Medicine 2024 被引用: 375

  8. Association between pathologic response and survival after neoadjuvant therapy in lung cancer

    著者: Julie S. Deutsch, Ashley Cimino‐Mathews, Elizabeth D. Thompson, Mariano Provencio, Patrick M. Forde, Jonathan Spicer, Nicolas Girard, Daphne Wang, Robert A. Anders, Edward Gabrielson, Peter B. Illei, Jaroslaw Jedrych, Ludmila Danilova, Joel Sunshine, Keith M. Kerr, Mia Tran, Judith Bushong, Junliang Cai, Vipul Devas, Jaclyn Neely, David Balli, Tricia R. Cottrell, Alex S. Baras, Janis M. Taube - Nature Medicine 2023 被引用: 162

  9. Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

    著者: Nicolas Girard, Jair Bar, Pilar Garrido, Marina Chiara Garassino, Fiona McDonald, F. Mornex, Andrea Riccardo Filippi, Hans J.M. Smit, Solange Peters, John K. Field, Daniel C. Christoph, Anne Sibille, Rainer Fietkau, Vilde Drageset Haakensen, C. Chouaïd, Ben Markman, T. Jeroen N. Hiltermann, Álvaro Taus, W. Sawyer, A. Allen, Pratibha Chander, Muriel Licour, Benjamin Solomon - Journal of Thoracic Oncology 2022 被引用: 226

  10. Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722

    著者: Tony Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi‐Long Wu, Justin F. Gainor, Se‐Hoon Lee, Chao‐Hua Chiu, Sang‐We Kim, Cheng‐Ta Yang, Chien Liang Wu, Lin Wu, Meng‐Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih‐Hsin Yang - Journal of Clinical Oncology 2024 被引用: 153

  11. Polygonal Building Extraction by Frame Field Learning

    著者: Nicolas Girard, Dmitriy Smirnov, Justin Solomon, Yuliya Tarabalka - IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2021 被引用: 119

  12. Contribution of resident and circulating precursors to tumor-infiltrating CD8 + T cell populations in lung cancer

    著者: Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin‐Givelet, Marine Lefèvre, Thierry Mora, Aleksandra M. Walczak, Joshua J. Waterfall, Sebastián Amigorena - Science Immunology 2021 被引用: 179

  13. LBA14 Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial

    著者: B.C. Cho, Enriqueta Felip, Alexander I. Spira, Nicolas Girard, Jin Sun Lee, SH Lee, Y.V. Ostapenko, Pongwut Danchaivijitr, B. Liu, Adlinda Alip, Ernesto Korbenfeld, Josiane Mourão Dias, Tao Sun, Melissa Martínez, Joshua Bauml, Martin Shreeve, Seema Sethi, Roland E. Knoblauch, Hidetoshi Hayashi, Shun Lü - Annals of Oncology 2023 被引用: 83

  14. Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

    著者: Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons‐Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, M. Pérol, Céline Mascaux, Elena Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Min Hee Hong, Enriqueta Felip, Richard D. Hall, Óscar Juan, Daniel Brungs, Shun Lü, Marina Chiara Garassino, Michael Chargualaf, Yong Zhang, Paul Howarth, Deise Uema, Aaron Lisberg, Jacob Sands, for the TROPION-Lung01 Trial Investigators, Gastón Lucas Martinengo, Juan Puig, Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans ほか 61 名 - Journal of Clinical Oncology 2024 被引用: 182

  15. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

    著者: Luis Paz‐Ares, Óscar Juan, Giannis Mountzios, Enriqueta Felip, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M. Patel, Takayuki Takahama, Scott Owen, Douglas Reznick, Firas Badin, İrfan Çiçin, Sabeen Mekan, Riddhi Patel, Éric Zhang, Divyadeep Karumanchi, Marina Chiara Garassino, Elizabeth Ahern, Venessa Chin, Stephen Della‐Fiorentina, Kevin Jasas, Christos S. Karapetis, Jeremy Long, Louise Nott, Kenneth J. O’Byrne, Craig Underhill, Richard Greil, Maximilian J. Hochmair, Andreas Pircher, Wim Demey, Paul Germonpré, Elke Govaerts, Thierry Pieters, Reinier Wener, Alan A. Azambuja, Giuliano Santos Borges, Gilberto de Castro, Suellen Castro, Felipe Melo Cruz, Fábio Franke, Eduardo Silva, Parneet Cheema, Robert H. El-Maraghi, Swati Kulkarni, Rami Nassabein, Scott Owen, Clarisse Audigier-Valette, Jaafar Bennouna, C. Chouaïd, Alexis B. Cortot, S. Couraud, D. Debieuvre, Fabrice Denis, Patrick Dumont, Radj Gervais, Nicolas Girard, Etienne Giroux‐Leprieur, Florian Guisier, Sandrine Hiret, Henri Janicot, Corinne Lamour, J. Madelaine, M. Marcq, E. Pluquet, Jean Louis Pujol, Magali Ravoire, Marielle Sabatini, A. Vergnenègre, Sabine Bohnet, Martin Faehling, Melanie Janning, Eckart Laack, Niels Reinmuth, Achim Rittmeyer, Claas Wesseler, Sofia Baka, George Fountzilas, Panagiotis Katsaounis, Αthanasios Kotsakis, Ioannis Mountzios, Konstantinos Syrigos, Julia Dudnik, Fink Carmel, Ofer Merimsky, Hovav Nechushtan, Julia Sobolev, Franceso Agustoni, Anna Bettini, Matteo Brighenti, Giulio Cerea, Filippo de Marinis, Salvatore Grisanti, Francesco Grossi, Andrea Luciani, Evaristo Maiello, Héctor Soto Parrà, Pierfrancesco Tassone, Giuseppe Tonini, Yoko Agemi ほか 101 名 - Journal of Clinical Oncology 2024 被引用: 115

  16. Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer

    著者: Antonela Merlotti, Benjamin Sadacca, Yago A. Arribas, Mercia Ngoma, Marianne Burbage, Christel Goudot, Alexandre Houy, Ares Rocañín-Arjó, Ana I. Lalanne, Agathe Seguin‐Givelet, Marine Lefèvre, Sandrine Heurtebise-Chrétien, Blandine Baudon, Giacomo Oliveira, Damarys Loew, Montserrat Carrascal, Catherine J. Wu, Olivier Lantz, Marc‐Henri Stern, Nicolas Girard, Joshua J. Waterfall, Sebastián Amigorena - Science Immunology 2023 被引用: 106

  17. Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

    著者: Ali Chour, Julie Denis, Céline Mascaux, M. Zysman, L. Bigay-Gamé, Aurélie Swalduz, V. Gounant, Alexis B. Cortot, Marie Darrason, Vincent Fallet, Édouard Auclin, Clémence Basse, Claire Tissot, C. Decroisette, P. Bombaron, Etienne Giroux‐Leprieur, L. Odier, Solenn Brosseau, Quentin Creusot, M. Gueçamburu, Corentin Meersseman, Adrien Rochand, Adrien Costantini, Claire Marine Gaillard, Eric Wasielewski, Nicolas Girard, Jacques Cadranel, Claire Lafitte, Fanny Lebossé, M. Duruisseaux - Journal of Thoracic Oncology 2023 被引用: 72

  18. Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

    著者: Myriam Delaunay, J. Cadranel, Amélie Lusque, Nicolás Meyer, V. Gounant, Denis Moro‐Sibilot, Jean‐Marie Michot, Judith Raimbourg, Nicolas Girard, Florian Guisier, David Planchard, Anne-Cécile Métivier, Pascale Tomasini, Éric Dansin, M. Pérol, M. Campana, Oliver Gautschi, Martin Früh, Jean-David Fumet, Clarisse Audigier-Valette, S. Couraud, Stéphane Dalle, M.‐T. Leccia, M. Jaffro, S. Collot, Grégoire Prévôt, Julie Milia, Julien Mazières - European Respiratory Journal 2017 被引用: 421

  19. Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

    著者: D. Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan W. Goldman, Fedor Moiseenko, Е. А. Филиппова, İrfan Çiçin, Tudor–Eliade Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope A. Bradbury, Mor Moskovitz, Nuran Katgı, Pascale Tomasini, Alona Zer, Nicolas Girard, Kristof Cuppens, Ji‐Youn Han, Shang‐Yin Wu, Shobhit Baijal, Aaron S. Mansfield, Chih‐Hsi S. Kuo, Kazumi Nishino, Se‐Hoon Lee, David Planchard, Christina S. Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine K. Ratajczak, Shun Lü - Journal of Clinical Oncology 2024 被引用: 135

  20. LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

    著者: M-J. Ahn, Aaron Lisberg, Luis Paz‐Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons‐Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, M. Pérol, Céline Mascaux, Elena Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Jacob Sands, Richard D. Hall, Yong Zhang, H. Zebger-Gong, Deise Uema, Isamu Okamoto - Annals of Oncology 2023 被引用: 55

  21. New driver mutations in non-small-cell lung cancer

    著者: William Pao, Nicolas Girard - The Lancet Oncology 2011 被引用: 1,135

  22. UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

    著者: Jair Bar, Nir Peled, Shiruyeh Schokrpur, Mirjana Wolner, Ofer Rotem, Nicolas Girard, Frank Aboubakar Nana, Sofie Derijcke, Waleed Kian, Sandip Pravin Patel, Hadas Gantz-Sorotsky, Alona Zer, Mor Moskovitz, Giulio Metro, Yakir Rottenberg, Antonio Calles, Maximilian J. Hochmair, Kristof Cuppens, Lynn Decoster, Martin Reck, Dror Limon, Estelamari Rodríguez, Christoforos Astaras, Adrienne Bettini, Simon Häfliger, Alfredo Addeo - Journal of Thoracic Oncology 2022 被引用: 97

  23. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Nicolas Girard, Enrico Ruffini, Alexander Marx, Corinne Faivre‐Finn, Solange Peters - Annals of Oncology 2015 被引用: 501

  24. Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

    著者: François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, Jean‐Marie Michot, Émilie Routier, Laurent Taillade, Stéphane Champiat, Sandrine Aspeslagh, Julien Haroche, Laurence Albigès, Christophe Massard, Nicolas Girard, Stéphane Dalle, Benjamin Besse, Salim Laghouati, Jean‐Charles Soria, Christine Mateus, Caroline Robert, Émilie Lanoy, Aurélien Marabelle, Olivier Lambotte - European Journal of Cancer 2018 被引用: 311